Nadin Cron

发表

Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)

A. Reuss, J. Ledermann, F. Marmé, 2020, International Journal of Gynecological Cancer.